Outcomes of re-referrals of patients with alcohol-associated liver disease, who were previously declined for liver transplantation

被引:2
|
作者
Cox, Ben [1 ]
Carrique, Lauren [1 ]
Di Maira, Tommaso [1 ,2 ,3 ,4 ]
Sales, Isabel [1 ]
Don, Caitlin [5 ]
Gomez-Aldana, A. [1 ]
Koshy, Dilip [5 ]
Abbey, Susan [5 ]
Lilly, Les [1 ]
Tsien, Cynthia [1 ]
Bhat, Mamatha [1 ,6 ]
Jaeckel, Elmar [1 ]
Lynch, Marie-Josee [1 ,5 ]
Selzner, Nazia [1 ,7 ]
机构
[1] Univ Toronto, Univ Hlth Network, Ajmera Transplant Ctr, Toronto, ON, Canada
[2] Hosp Univ La Fe, Liver Transplantat & Hepatol Unit, Valencia, Spain
[3] Inst Salud Carlos III, CIBERehd, Madrid, Spain
[4] IIS La Fe, Valencia, Spain
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[6] Univ Toronto, Dept Med, Toronto, ON, Canada
[7] Toronto Gen Hosp, Ajmera Transplant Ctr, Toronto, ON M5M2P3, Canada
关键词
D O I
10.1097/LVT.0000000000000274
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Since 2018, our program has utilized specific psychosocial criteria and a multidisciplinary approach to assess patients for liver transplant due to alcohol-associated liver disease (ALD), rather than the 6-month abstinence rule alone. If declined based on these criteria, specific recommendations are provided to patients and their providers regarding goals for re-referral to increase the potential for future transplant candidacy. Recommendations include engagement in treatment for alcohol use disorder, serial negative biomarker testing, and maintenance of abstinence from alcohol. In our current study, we evaluate the outcomes of patients with ALD, who were initially declined upon assessment and re-referred to our program. This is a retrospective cohort study that includes 98 patients with ALD, who were previously declined for liver transplantation and were subsequently re-referred for liver transplant assessment between May 1, 2018, and December 31, 2021. We assess the outcomes of patients who were re-referred including acceptance for transplantation following a second assessment. Of the 98 patients who were re-referred, 46 (46.9%) fulfilled the recommendations made and proceeded to further medical evaluation. Nine were eventually transplanted; others are listed and are waiting for transplant. The presence of a partner was independently associated with a higher rate of acceptance (OR 0.16, 95% CI: 0.03-0.97, p = 0.05). Most of the patients who did not proceed further (n = 52) were declined again due to ALD contraindications (n = 33, 63.4%), including ongoing drinking and lack of engagement in recommended addiction treatment. Others had medical contraindications (11.2%), clinically improved (6.1%), had adherence issues (5.1%), or lack of adequate support (2%). Patients with ALD previously declined for a liver transplant can be re-referred and successfully accepted for transplantation by fulfilling the recommendations made by the multidisciplinary team. Important factors including ongoing abstinence, engagement in addiction treatment, and social support are key for successful acceptance.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 50 条
  • [31] Recidivism and post-transplant outcomes in patients with alcohol-associated liver disease
    Najafian, Nilofar
    Kagbo-Kue, Suaka
    Punukollu, Rachana
    Liu, Margaret C.
    Budvytyte, Laura
    Li, Xingjie
    McGary, Alyssa K.
    Chascsa, David M. H.
    Jadlowiec, Caroline
    Jayasekera, Channa
    Barnhill, Michele S.
    Dickson, Rolland
    JOURNAL OF HEPATOLOGY, 2024, 80 : S152 - S153
  • [32] Letter: Association of myokines with disease progression and outcomes in patients with alcohol-associated liver disease
    Lv, Jianyu
    Ying, Yize
    Du, Chenfei
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1475 - 1476
  • [33] Recovery and outcomes of patients denied early liver transplantation for severe alcohol-associated hepatitis
    Musto, Jessica
    Stanfield, Dylan
    Ley, Dana
    Lucey, Michael R.
    Eickhoff, Jens
    Rice, John P.
    HEPATOLOGY, 2022, 75 (01) : 104 - 114
  • [34] Surgical Outcomes of Limited Sobriety versus Standard Sobriety Liver Transplantation for Alcohol-Associated Liver Disease.
    Fu, S.
    Pan, J. H.
    Goel, A.
    Kwong, A. J.
    Melcher, M. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 723 - 723
  • [35] Outcomes of severe alcohol-associated hepatitis with or without early liver transplantation
    Bekki, Yuki
    Fenig, Yaniv
    HEPATOLOGY, 2022, 75 (02) : 500 - 500
  • [36] Pathogenesis of Alcohol-Associated Liver Disease
    Mandrekar, Pranoti
    Mandal, Abhishek
    CLINICS IN LIVER DISEASE, 2024, 28 (04) : 647 - 661
  • [37] Liver Iron Loading in Alcohol-Associated Liver Disease
    Ali, Najma
    Ferrao, Kevin
    Mehta, Kosha J.
    AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (10): : 1427 - 1439
  • [38] Imaging of Alcohol-Associated Liver Disease
    Maheshwari, Sharad
    Gu, Chris N.
    Caserta, Melanie P.
    Kezer, Camille A.
    Shah, Vijay H.
    Torbenson, Michael S.
    Menias, Christine O.
    Fidler, Jeff L.
    Venkatesh, Sudhakar K.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2024, 222 (01)
  • [39] Liver transplantation in alcohol-associated liver disease: ensuring equity through new processes
    Messinger, John C. C.
    Hanto, Douglas W. W.
    Curry, Michael P. P.
    Ladin, Keren
    LIVER TRANSPLANTATION, 2023, 29 (05) : 539 - 547
  • [40] Pathogenesis of Alcohol-Associated Liver Disease*
    Osna, Natalia A.
    Rasineni, Karuna
    Ganesan, Murali
    Donohue, Terrence M.
    Kharbanda, Kusum K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (06) : 1492 - 1513